arrow
S

Sæmundur Rögnvaldsson

University of Iceland
H指数:11
被引数:628

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Detailed immunophenotypic and genetic characterization of bone marrow clonal plasma cells and B-cells in early-stage monoclonal gammopathies

早期单克隆丙种球蛋白病患者骨髓克隆性浆细胞和B细胞的详细免疫表型及遗传学特征分析

2026-07-180
OA
Redefining light-chain smoldering multiple myeloma: prevalence and progression risk

重新定义轻链冒烟性多发性骨髓瘤:患病率及进展风险

Leukemia
IF13.4
2026-07-060
OAAI
Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study

SARS-CoV-2疫苗接种对意义未明的单克隆丙种球蛋白血症的影响:基于人群的iStopMM研究的结果

2026-04-110
OAAI
Dietary intake and the risk of monoclonal gammopathy of undetermined significance: results from the population-based iStopMM screening study

饮食摄入与意义未明的单克隆丙种球蛋白病的风险:来自基于人群的iStopMM筛查研究的结果

2026-04-080
OAAI
Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: apopulation-based study by the Nordic Myeloma Study Group

对年龄>65岁骨髓瘤患者采用自体干细胞移植的前瞻性研究:一项由北欧骨髓瘤研究组进行的人群研究

2026-02-010
OA
Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study

弥漫性多发性骨髓瘤患者感染风险增加:来自筛查的iStopMM研究的结果

Leukemia
IF13.4
2025-09-120
OAAI
Next-generation flow cytometry analysis of clonal bone marrow plasma cells identifies an indolent subset of MGUS

下一代流式细胞术分析克隆性骨髓浆细胞,识别出一类惰性MGUS亚群

2025-08-210
OAAI
Cytogenetic abnormalities in multiple myeloma patients according to age: A real-world study by the Nordic Myeloma Study Group

多发性骨髓瘤患者按年龄分组的细胞遗传学异常:一项由北欧骨髓瘤研究组进行的大型真实世界研究

2025-07-230
OAAI
Correction: Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis

修正:修订后的游离轻链参考区间可增强意义未明的单克隆 gammopathy 的风险分层,并减少过度诊断

2025-05-270
OAAI
The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance: a flow cytometry sub-study of the iStopMM screening study

游离轻链比值在意义未明的轻链型单克隆免疫球蛋白血症中的意义:iStopMM筛查研究中的流式细胞术亚组研究

2024-12-180
OAAI
Analysis of smoldering multiple myeloma according to the target of the monoclonal immunoglobulin of patients
2024-12-110
OAAI
Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population-based screening study
2024-11-190
OAAI
Deciphering the genetics and mechanisms of predisposition to multiple myeloma

解读多发性骨髓瘤易感性的遗传学和机制

2024-08-052
OAAI
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance
2024-06-180
PRE
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined SignificanceA Cohort Study Nested in a Clinical Trial
2024-04-011
PRE
Prior cancer and risk of monoclonal gammopathy of undetermined significance: a population-based study in Iceland and Sweden
2024-01-110
OAAI
Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study
2023-12-110
OAAI
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index
2023-12-013
OAAI